S

Surrozen
D

SRZN

26.950
USD
-1.76
(-6.13%)
مغلق
حجم التداول
1,637
الربح لكل سهم
-5
العائد الربحي
-
P/E
-2
حجم السوق
230,999,796
المقالات

العنوان: Surrozen

القطاع: Healthcare
الصناعة: Biotechnology
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).